Angelika Vlachou

Angelika Vlachou is a partner at High-Tech Gründerfonds (HTGF), one of Europes most active seed investors. She is jointly responsible for HTGF´s activities in the life science and chemistry sectors and serves on board of portfolio companies. Angelika has been investing venture capital in biotech, pharma, and life science start-ups for over 10 years. Over the course of her career, she has managed many transactions ranging from seed-stage venture capital and growth financing to licensing agreements, trade sale transactions and IPOs. Her expertise is also based on her virology-molecular biology research experience. One of her strengths is to combine scientific innovation with commercial potential. She is a valued sparring partner for founders, investors, and stakeholders. With a doctorate in biology, she started her professional career in investment banking.